Host-pathogen interactions: The role of iron

Journal of Nutrition

Volumn 137, Issue 5, 2007, Pages 1341-1344

  Doherty, Conor P ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADAPTIVE BEHAVIOR; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG CONTRAINDICATION; DRUG FATALITY; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY DISEASE; INTERSPECIFIC COMPETITION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM DISORDER; IRON THERAPY; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OVERNUTRITION; PHAGOSOME; PLASMODIUM FALCIPARUM; SIDE EFFECT; TUBERCULOSIS; VIRUS VIRULENCE;

EID: 34247893749     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.5.1341     Document Type: Conference Paper

References (41)

1. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117:285-97.
2. Knutson M, Wessling-Resnick M. Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol. 2003;38:61-88.
3. Bullen J, Griffiths E, Rogers H, Ward G. Sepsis: the critical role of iron. Microbes Infect. 2000;2:409-15.
4. Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Iron and infection: the heart of the matter. FEMS Immunol Med Microbiol. 2005;43:325-30.
5. Bullen J, Griffiths E. Iron and infection. Molecular, physiological and clinical aspects. 2nd ed. Chichester: Wiley; 1999.
6. Barry DM, Reeve AW. Increased incidence of gram-negative neonatal sepsis with intramuscula iron administration. Pediatrics. 1977;60: 908-12.
7. Kelly DA, Price E, Jani B, Wright V, Rossiter M, Walker-Smith JA. Yersinia enterocolitis in iron overload. J Pediatr Gastroenterol Nutr. 1987;6:643-5.
8. Leclercq A, Martin L, Vergnes ML, Ounnoughene N, Laran JF, Giraud P, Carniel E. Fatal Yersinia enterocolitica biotype 4 serovar O:3 sepsis after red blood cell transfusion. Transfusion. 2005;45:814-8.
9. Clermont O, Bonacorsi S, Bingen E. The Yersinia high-pathogenicity island is highly predominant in virulence-associated phylogenetic groups of Escherichia coli. FEMS Microbiol Lett. 2001;196:153-7.
10. Ratledge C. Iron, mycobacteria and tuberculosis. Tuberculosis (Edinb). 2004;84:110-30.
11. Gruenheid S, Canonne-Hergaux F, Gauthier S, Hackam DJ, Grinstein S, Gros P. The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med. 1999;189:831-41.
12. Agranoff D, Monahan IM, Mangan JA, Butcher PD, Krishna S. Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J Exp Med. 1999; 190:717-24.
13. Blackwell JM. Genetics and genomics in infectious disease susceptibility. Trends Mol Med. 2001;7:521-6.
14. Ryu SY, Jeong KS, Kang BN, Park SJ, Yoon WK, Kim SH, Kim TH. Modulation of transferrin synthesis, transferrin receptor expression, iNOS expression and NO production in mouse macrophages by cytokines, either alone or in combination. Anticancer Res. 2000;20:3331-8.
15. Gomes MS, Boelaert JR, Appelberg R. Role of iron in experimental Mycobacterium avium infection. J Clin Virol. 2001;20:117-22.
16. Wanachiwanawin W. Infections in E-beta thalassemia. J Pediatr Hematol Oncol. 2000;22:581-7.
17. Gordeuk VR, McLaren CE, MacPhail AP, Deichsel G, Bothwell TH. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood. 1996;87: 3470-6.
18. de Monye C, Karcher DS, Boelaert JR, Gordeuk VR. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS. 1999;13:375-80.
19. Chandra RK. Nutritional deficiency and susceptibility to infection. Bull World Health Organ. 1979;57:167-77.
20. Gangaidzo IT, Moyo VM, Mvundura E, Aggrey G, Murphree NL, Khumalo H, Saungweme T, Kasvosve I, Gomo ZA, et al. Association of pulmonary tuberculosis with increased dietary iron. J Infect Dis. 2001; 184:936-9.
21. Kasvosve I, Gomo ZA, Mvundura E, Moyo VM, Saungweme T, Khumalo H, Gordeuk VR, Boelaert JR, Delanghe JR, et al. Haptoglobin polymorphism and mortality in patients with tuberculosis. Int J Tuberc Lung Dis. 2000;4:771-5.
22. McDermid JM, Prentice AM. Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. Clin Sci (Lond). 2006;110:503-24.
23. Nanda NK, Das BS. Presence of pro-oxidants in plasma of patients suffering from falciparum malaria. Trans R Soc Trop Med Hyg. 2000; 94:684-8.
24. Phillips RE, Looareesuwan S, Warrell DA, Lee SH, Karbwang J, Warrell MJ, White NJ, Swasdichai C, Weatherall DJ. The importance of anaemia in cerebral and uncomplicated falciparum malaria: role of complications, dyserythropoiesis and iron sequestration. Q J Med. 1986; 58:305-23.
25. Abdalla S, Weatherall DJ, Wickramasinghe SN, Hughes M. The anaemia of P. falciparum malaria. Br J Haematol. 1980;46:171-83.
26. Verhoef H, West CE, Kraaijenhagen R, Nzyuko SM, King R, Mbandi MM, van Laatum S, Hogervorst R, Schep C, et al. Malarial anemia leads to adequately increased erythropoiesis in asymptomatic Kenyan children. Blood. 2002;100:3489-94.
27. Metzger WG, Mordmuller BG, Kremsner PG. Malaria pigment in leucocytes. Trans R Soc Trop Med Hyg. 1995;89:637-8.
28. Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp Med. 1992;176:1033-41.
29. Taramelli D, Basilico N, Pagani E, Grande R, Monti D, Ghione M, Olliaro P. The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide- stimulated macrophages. Exp Parasitol. 1995;81:501-11.
30. Schwarzer E, Alessio M, Ulliers D, Arese P. Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes. Infect Immun. 1998;66:1601-6.
31. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, Ngetsa C, Slack MP, Njenga S, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352:39-47.
32. Berkley J, Mwarumba S, Bramham K, Lowe B, Marsh K. Bacteraemia complicating severe malaria in children. Trans R Soc Trop Med Hyg. 1999;93:283-6.
33. Nyakeriga AM, Troye-Blomberg M, Dorfman JR, Alexander ND, Back R, Kortok M, Chemtai AK, Marsh K, Williams TN. Iron deficiency and malaria among children living on the coast of Kenya. J Infect Dis. 2004;190:439-47.
34. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet. 2006; 367:133-43.
35. de Monye C, Karcher DS, Boelaert JR, Gordeuk VR. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS. 1999;13:375-80.
36. Georgiou NA, van der BT, Oudshoorn M, Nottet HS, Marx JJ, Van Asbeck BS. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis. 2000;181:484-90.
37. Traore HN, Meyer D. The effect of iron overload on in vitro HIV-1 infection. J Clin Virol. 2004;31 Suppl 1:S92-8.
38. Friis H, Gomo E, Nyazema N, Ndhlovu P, Krarup H, Madsen PH, Michaelsen KF. Iron, haptoglobin phenotype, and HIV-1 viral load: a cross-sectional study among pregnant Zimbabwean women. J Acquir Immune Defic Syndr. 2003;33:74-81.
39. Costagliola DG, de Montalembert M, Lefrere JJ, Briand C, Rebulla P, Baruchel S, Dessi C, Fondu P, Karagiorga M, et al. Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients. Br J Haematol. 1994;87:849-52.
40. Delanghe JR, Langlois MR, Boelaert JR, Van Acker J, Van Wanzeele F, van der Groen G, Hemmer R, Verhofstede C, De Buyzere M, et al. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS. 1998;12:1027-32.
41. Quaye IK, Brandful J, Ekuban FA, Gyan B, Ankrah NA. Haptoglobin polymorphism in human immunodeficiency virus infection: Hp0 phenotype limits depletion of CD4 cell counts in HIV-1-seropositive individuals. J Infect Dis. 2000;181:1483-5.